Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 415.70
+2.05 (0.50%)
At close: Jun 19, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 681.5 billion as of June 22, 2026. Its market cap has increased by 70.49% in one year.
Market Cap
681.50B
Enterprise Value
822.90B
Revenue
169.27B
Ranking
n/a
PE Ratio
176.74
Stock Price
415.70
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 681.50B, an increase of 1,400.66%. That is a compound annual growth rate of 12.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 681.50B | 29.65% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 33.84B |
| Titan Biotech | 17.94B |
| Hester Biosciences | 17.67B |
| CCME Global | 5.12B |
| Zenotech Laboratories | 2.71B |
| Bharat Immunologicals & Biologicals Corporation | 750.47M |
| Transgene Biotek | 228.83M |
| Hindustan Bio Sciences | 77.70M |